Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Performance of a PLK1-based immune risk model for prognosis and treatment response prediction in breast cancer. | Cancer Med | 2023 | 36951624 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. | Front Immunol | 2023 | 36949947 | PubTator, text mining | PubMed |
| Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature. | J Transl Med | 2023 | 36941725 | PubTator, text mining | PubMed |
| Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors. | Cancer Discov | 2023 | 36939219 | PubTator, text mining | PubMed |
| Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity. | Front Pharmacol | 2023 | 36937841 | PubTator, text mining | PubMed |
| Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma. | Nat Commun | 2023 | 36934096 | PubTator, text mining | PubMed |
| HSV: The scout and assault for digestive system tumors. | Front Mol Biosci | 2023 | 36926680 | PubTator, text mining | PubMed |
| A YAP/TAZ-CD54 axis is required for CXCR2-CD44- tumor-specific neutrophils to suppress gastric cancer. | Protein Cell | 2023 | 36921037 | PubTator, text mining | PubMed |
| Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets. | Aging (Albany NY) | 2023 | 36920183 | PubTator, text mining | PubMed |
| High levels of LIGHT/TNFSF14 in patients with Prader-Willi syndrome. | J Endocrinol Invest | 2023 | 36917420 | PubTator, text mining | PubMed |
| A cuproptosis-related signature for predicting the prognosis of gastric cancer. | J Gastrointest Oncol | 2023 | 36915443 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma. | Hum Genomics | 2023 | 36915193 | PubTator, text mining | PubMed |
| NFκB signaling in T cell memory. | Front Immunol | 2023 | 36911729 | PubTator, text mining | PubMed |
| Transcriptional reprogramming of natural killer cells by vaccinia virus shows both distinct and conserved features with mCMV. | Front Immunol | 2023 | 36911702 | PubTator, text mining | PubMed |
| Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis. | Front Genet | 2023 | 36911389 | PubTator, text mining | PubMed |
| B Cells in Breast Cancer Pathology. | Cancers (Basel) | 2023 | 36900307 | PubTator, text mining | PubMed |
| Special Issue "Cutaneous Lymphomas". | Cancers (Basel) | 2023 | 36900273 | PubTator, text mining | PubMed |
| Distinct roles of ADIPOR1 and ADIPOR2: A pan-cancer analysis. | Front Endocrinol (Lausanne) | 2023 | 36896172 | PubTator, text mining | PubMed |
| Integration of bulk RNA sequencing and single-cell analysis reveals a global landscape of DNA damage response in the immune environment of Alzheimer's disease. | Front Immunol | 2023 | 36895559 | PubTator, text mining | PubMed |
| Cytotoxic CD161-CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. | EBioMedicine | 2023 | 36893588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=34